Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1

Journal of Neurochemistry

Volumn 117, Issue 4, 2011, Pages 643-653

  Lee, Ming Jen ^a   Chien, Wei Lin ^a   Lee, Tzeng Ruei ^a   Hung, Shih Ya ^a   Kang, Kai Hsiang ^a   Fu, Wen Mei ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

heme oxygenase 1; Parkinson's disease; PTEN induced putative kinase 1; tumor necrosis factor receptor associated protein 1

Indexed keywords

HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE AND TENSIN HOMOLOG INDUCED PUTATIVE KINASE 1; PROTEIN KINASE B; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; GENE MUTATION; HUMAN; HUMAN CELL; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOVIRIDAE; BENZIMIDAZOLES; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; COLORING AGENTS; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEME OXYGENASE-1; HSP90 HEAT-SHOCK PROTEINS; HUMANS; L-LACTATE DEHYDROGENASE; MUTATION; OXIDATIVE STRESS; PARKINSON DISEASE, SECONDARY; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TETRAZOLIUM SALTS; THIAZOLES;

ADENOVIRIDAE;

EID: 79955046650     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07229.x     Document Type: Article

References (39)

1. Applegate L. A., Luscher P., and, Tyrrell R. M., (1991) Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51, 974-978.
2. Beilina A., Van Der Brug M., Ahmad R., Kesavapany S., Miller D. W., Petsko G. A., and, Cookson M. R., (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA 102, 5703-5708. (Pubitemid 40559623)
3. Burke R. E., (2007) Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol. Ther. 114, 261-277. (Pubitemid 46844843)
4. Carette J., Lehnert S., and, Chow T. Y., (2002) Implication of PBP74/mortalin/GRP75 in the radio-adaptive response. Int. J. Radiat. Biol. 78, 183-190. (Pubitemid 34208322)
5. Cechetto J. D., Soltys B. J., and, Gupta R. S., (2000) Localization of mitochondrial 60-kD heat shock chaperonin protein (Hsp60) in pituitary growth hormone secretory granules and pancreatic zymogen granules. J. Histochem. Cytochem. 48, 45-56. (Pubitemid 30053565)
6. Cuadrado A., and, Rojo A. I., (2008) Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr. Pharm. Des. 14, 429-442. (Pubitemid 351516848)
7. Furukawa Y., Urano T., Minamimura M., Nakajima M., Okuyama S., and, Furukawa S., (2010) 4-Methylcatechol-induced heme oxygenase-1 exerts a protective effect against oxidative stress in cultured neural stem/progenitor cells via PI3 kinase/Akt pathway. Biomed. Res. 31, 45-52.
8. Gasser T., (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 11, 1-20.
9. Haque M. E., Thomas K. J., D'Souza C., et al. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl Acad. Sci. USA 105, 1716-1721. (Pubitemid 351346580)
10. Hoepken H. H., Gispert S., Morales B., et al. (2007) Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol. Dis. 25, 401-411. (Pubitemid 46124020)
11. Hu C. M., Chen Y. H., Chiang M. T., and, Chau L. Y., (2004) Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 110, 309-316.
12. Hung S. Y., Liou H. C., Kang K. H., Wu R. M., Wen C. C., and, Fu W. M., (2008) Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol. Pharmacol. 74, 1564-1575.
13. Juan S. H., Lee T. S., Tseng K. W., Liou J. Y., Shyue S. K., Wu K. K., and, Chau L. Y., (2001) Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104, 1519-1525. (Pubitemid 32917345)
14. Le W. D., Xie W. J., and, Appel S. H., (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 56, 652-658. (Pubitemid 29246847)
15. Lee A. S., (2001) The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26, 504-510. (Pubitemid 32735452)
16. Ma Z. C., Hong Q., Wang Y. G., Tan H. L., Xiao C. R., Liang Q. D., Zhang B. L., and, Gao Y., (2010) Ferulic acid protects human umbilical vein endothelial cells from radiation induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Biol. Pharm. Bull. 33, 29-34.
17. Maj M. C., Tkachyova I., Patel P., et al. (2010) Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells. Biochem. Biophys. Res. Commun. 399, 331-335.
18. Masuda Y., Shima G., Aiuchi T., Horie M., Hori K., Nakajo S., Kajimoto S., Shibayama-Imazu T., and, Nakaya K., (2004) Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J. Biol. Chem. 279, 42503-42515. (Pubitemid 39372134)
19. Mateo I., Infante J., Sanchez-Juan P., Garcia-Gorostiaga I., Rodriguez-Rodriguez E., Vazquez-Higuera J. L., Berciano J., and, Combarros O., (2010) Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol. Scand. 121, 136-138.
20. Michiorri S., Gelmetti V., Giarda E., et al. (2010) The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ. 17, 962-974.
21. Mills R. D., Sim C. H., Mok S. S., Mulhern T. D., Culvenor J. G., and, Cheng H. C., (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J. Neurochem. 105, 18-33. (Pubitemid 351441646)
22. Nussbaum R. L., and, Ellis C. E., (2003) Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348, 1356-1364. (Pubitemid 36384104)
23. Petit A., Kawarai T., Paitel E., et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025-34032. (Pubitemid 41443124)
24. Pridgeon J. W., Olzmann J. A., Chin L. S., and, Li L., (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5, 1494-1503. (Pubitemid 47105341)
25. Prochiantz A., di Porzio U., Kato A., Berger B., and, Glowinski J., (1979) In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc. Natl Acad. Sci. USA 76, 5387-5391. (Pubitemid 10231637)
26. Rogaeva E., Johnson J., Lang A. E., et al. (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch. Neurol. 61, 1898-1904. (Pubitemid 39612950)
27. Ryter S. W., Otterbein L. E., Morse D., and, Choi A. M., (2002) Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234-235, 249-263. (Pubitemid 34777864)
28. Ryter S. W., Alam J., and, Choi A. M., (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650.
29. Schipper H. M., (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 37, 1995-2011. (Pubitemid 39491319)
30. Schipper H. M., Song W., Zukor H., Hascalovici J. R., and, Zeligman D., (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J. Neurochem. 110, 469-485.
31. Sha D., Chin L. S., and, Li L., (2009) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum. Mol. Genet. 19, 352-363.
32. Shan Y., Liu B., Li L., et al. (2009) Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury. J. Neurochem. 111, 1149-1160.
33. Song H. Y., Dunbar J. D., Zhang Y. X., Guo D., and, Donner D. B., (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270, 3574-3581.
34. Valente E. M., Abou-Sleiman P. M., Caputo V., et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160. (Pubitemid 38661852)
35. Voloboueva L. A., Duan M., Ouyang Y., Emery J. F., Stoy C., and, Giffard R. G., (2008) Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. J. Cereb. Blood Flow Metab. 28, 1009-1016. (Pubitemid 351589637)
36. Xiang F., Huang Y. S., Shi X. H., and, Zhang Q., (2010) Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J. 277, 1929-1938.
37. Xie H. R., Hu L. S., and, Li G. Y., (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin. Med. J. 123, 1086-1092.
38. Xu L., Voloboueva L. A., Ouyang Y., Emery J. F., and, Giffard R. G., (2009) Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J. Cereb. Blood Flow Metab. 29, 365-374.
39. Zhou C., Huang Y., Shao Y., May J., Prou D., Perier C., Dauer W., Schon E. A., and, Przedborski S., (2008) The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl Acad. Sci. USA 105, 12022-12027.